The deubiquitinating enzyme USP4 regulates BRCA1 stability and function.
Journal
NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891
Informations de publication
Date de publication:
11 May 2024
11 May 2024
Historique:
received:
24
06
2023
accepted:
01
05
2024
medline:
12
5
2024
pubmed:
12
5
2024
entrez:
11
5
2024
Statut:
epublish
Résumé
BRCA1 plays a suppressive role in breast tumorigenesis. Ubiquitin-dependent degradation is a common mechanism that regulates BRCA1 protein stability, and several ubiquitin ligases involved have been identified. However, the deubiquitinating enzyme for BRCA1 remains less defined. Here, we report that the deubiquitinase USP4 interacts with, deubiquitinates and stabilizes BRCA1, maintaining the protein level of BRCA1. USP4 knockdown results in a decreased BRCA1 protein level, impairment in homologous recombination mediated double-stranded break repair, and increased genome instability, and confers resistance to DNA damage-inducing agents and PARP inhibitors. Ectopic expression of USP4 stabilizes BRCA1 and reverse the effects caused by USP4 knockdown. Moreover, USP4 is low expressed in human breast cancer tissues and its low expression correlates with poorer survival of patients. Furthermore, we identified several loss-of-function mutations of USP4 in human gynecological cancers, the catalytic activity of which or their interaction with BRCA1 is disrupted. Together, we reveal that USP4 is a deubiquitinase for BRCA1. USP4 positively regulates the stability and function of BRCA1 through de-ubiquitination, and plays important role in the suppression of breast cancer.
Identifiants
pubmed: 38734703
doi: 10.1038/s41523-024-00641-7
pii: 10.1038/s41523-024-00641-7
doi:
Types de publication
Journal Article
Langues
eng
Pagination
35Subventions
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 82172924
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 81972477
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 81772953
Organisme : National Science Foundation of China | Major Research Plan
ID : 2017YFA0503900
Informations de copyright
© 2024. The Author(s).
Références
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
doi: 10.1126/science.7545954
pubmed: 7545954
Kwong, A. et al. Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian counties. J. Med. Genet. 53, 15–23 (2016).
pubmed: 26187060
doi: 10.1136/jmedgenet-2015-103132
Baldassarre, G. et al. Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol. Cell Biol. 23, 2225–2238 (2003).
pubmed: 12640109
pmcid: 150734
doi: 10.1128/MCB.23.7.2225-2238.2003
Zheng, W. et al. Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol. Oncol. 76, 294–300 (2000).
pubmed: 10684699
doi: 10.1006/gyno.1999.5664
Taylor, J. et al. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer 79, 334–342 (1998).
pubmed: 9699523
doi: 10.1002/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W
Bochar, D. A. et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257–265 (2000).
pubmed: 10943845
doi: 10.1016/S0092-8674(00)00030-1
Takaoka, M. & Miki, Y. BRCA1 gene: function and deficiency. Int. J. Clin. Oncol. 23, 36–44 (2018).
pubmed: 28884397
doi: 10.1007/s10147-017-1182-2
Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171–182 (2002).
pubmed: 11832208
doi: 10.1016/S0092-8674(02)00615-3
Yoshida, K. & Miki, Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 95, 866–871 (2004).
pubmed: 15546503
doi: 10.1111/j.1349-7006.2004.tb02195.x
Zhang, F. et al. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr. Biol. 19, 524–529 (2009).
pubmed: 19268590
pmcid: 2750839
doi: 10.1016/j.cub.2009.02.018
Mullan, P. B., Quinn, J. E. & Harkin, D. P. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 25, 5854–5863 (2006).
pubmed: 16998500
doi: 10.1038/sj.onc.1209872
Somasundaram, K. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair–perhaps through transcription. J. Cell Biochem. 88, 1084–1091 (2003).
pubmed: 12647291
doi: 10.1002/jcb.10469
Mallery, D. L., Vandenberg, C. J. & Hiom, K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 21, 6755–6762 (2002).
pubmed: 12485996
pmcid: 139111
doi: 10.1093/emboj/cdf691
Deng, Y. et al. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Oncogene 29, 6603–6608 (2010).
pubmed: 20818429
pmcid: 3081720
doi: 10.1038/onc.2010.406
Deng, Y. et al. Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. Mol Carcinog. 51, 500–507 (2012).
pubmed: 21681822
doi: 10.1002/mc.20813
De Siervi, A. et al. Transcriptional autoregulation by BRCA1. Cancer Res. 70, 532–542 (2010).
pubmed: 20068145
pmcid: 2952428
doi: 10.1158/0008-5472.CAN-09-1477
Wang, A., Schneider-Broussard, R., Kumar, A. P., MacLeod, M. C. & Johnson, D. G. Regulation of BRCA1 expression by the Rb-E2F pathway. J. Biol. Chem. 275, 4532–4536 (2000).
pubmed: 10660629
doi: 10.1074/jbc.275.6.4532
Korlimarla, A. et al. Identification of BRCA1 deficiency using multi-analyte estimation of BRCA1 and its repressors in FFPE tumor samples from patients with triple negative breast cancer. PLoS One 11, e0153113 (2016).
pubmed: 27077368
pmcid: 4831669
doi: 10.1371/journal.pone.0153113
Wu, W. et al. HERC2 is an E3 ligase that targets BRCA1 for degradation. Cancer Res. 70, 6384–6392 (2010).
pubmed: 20631078
doi: 10.1158/0008-5472.CAN-10-1304
Lu, Y. et al. The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. J. Biol. Chem. 287, 41014–41022 (2012).
pubmed: 23086937
pmcid: 3510804
doi: 10.1074/jbc.M112.407106
Wang, X. et al. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin–proteasome pathway. Biochem. Biophys. Res. Commun. 444, 290–295 (2014).
pubmed: 24342616
doi: 10.1016/j.bbrc.2013.12.053
Liu, F. et al. CRL4-DCAF8L1 regulates BRCA1 and BARD1 protein stability. Int. J. Biol. Sci. 18, 1434–1450 (2022).
pubmed: 35280675
pmcid: 8898372
doi: 10.7150/ijbs.57178
Peng, Y. et al. TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. Cancer Res. 75, 378–386 (2015).
pubmed: 25480944
doi: 10.1158/0008-5472.CAN-14-2315
Kim, S., Jin, H., Seo, H.-R., Lee, H. J. & Lee, Y.-S. Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation. Cell Death Differ 26, 812–825 (2019).
pubmed: 30006610
doi: 10.1038/s41418-018-0153-0
Clague, M. J., Urbé, S. & Komander, D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat. Rev. Mol. Cell Biol. 20, 338–352 (2019).
pubmed: 30733604
doi: 10.1038/s41580-019-0099-1
Li, W. et al. Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2. Genes Dev. 34, 1310–1315 (2020).
pubmed: 32943575
pmcid: 7528704
doi: 10.1101/gad.339804.120
Abdul Rehman, S. A. et al. MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes. Mol. Cell 63, 146–155 (2016).
pubmed: 27292798
pmcid: 4942677
doi: 10.1016/j.molcel.2016.05.009
Li, Y. & Yuan, J. Role of deubiquitinating enzymes in DNA double-strand break repair. J. Zhejiang Univ. Sci. B 22, 63–72 (2021).
pubmed: 33448188
pmcid: 7818009
doi: 10.1631/jzus.B2000309
Kee, Y. & Huang, T. T. Role of deubiquitinating enzymes in DNA repair. Mol. Cell Biol. 36, 524–544 (2016).
pubmed: 26644404
pmcid: 4751696
doi: 10.1128/MCB.00847-15
Lu, Q., Zhang, F.-L., Lu, D.-Y., Shao, Z.-M. & Li, D.-Q. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells. Cancer Med. 8, 6730–6740 (2019).
pubmed: 31512408
pmcid: 6825982
doi: 10.1002/cam4.2528
Liu, H. et al. The deubiquitylating enzyme USP4 cooperates with CtIP in DNA double-strand break end resection. Cell Rep. 13, 93–107 (2015).
Shao, G. et al. The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks. Proc. Natl. Acad. Sci. USA 106, 3166–3171 (2009).
pubmed: 19202061
pmcid: 2651241
doi: 10.1073/pnas.0807485106
Yu, H. et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 111, 285–290 (2014).
pubmed: 24347639
doi: 10.1073/pnas.1309085110
Jensen, D. E. et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097–1112 (1998).
pubmed: 9528852
doi: 10.1038/sj.onc.1201861
Nishikawa, H. et al. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res. 69, 111–119 (2009).
pubmed: 19117993
doi: 10.1158/0008-5472.CAN-08-3355
Uckelmann, M. et al. USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A. Nat. Commun. 9, 229 (2018).
pubmed: 29335415
pmcid: 5768779
doi: 10.1038/s41467-017-02653-3
Typas, D. et al. The de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80. Nucleic Acids Res. 43, 6919–6933 (2015).
pubmed: 26101254
pmcid: 4538816
doi: 10.1093/nar/gkv613
Li, Y. et al. USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response. Nat. Commun. 8, 15752 (2017).
pubmed: 28569838
pmcid: 5461494
doi: 10.1038/ncomms15752
Kim, H., Chen, J. & Yu, X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316, 1202–1205 (2007).
pubmed: 17525342
doi: 10.1126/science.1139621
O’Dea, R. & Santocanale, C. Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase. J. Cell Sci. 133, jcs233437 (2020).
Zhang, X., Berger, F. G., Yang, J. & Lu, X. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. EMBO J. 30, 2177–2189 (2011).
pubmed: 21522127
pmcid: 3117646
doi: 10.1038/emboj.2011.125
Zhao, B., Schlesiger, C., Masucci, M. G. & Lindsten, K. The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway. J. Cell Mol. Med. 13, 1886–1895 (2009).
pubmed: 20141612
pmcid: 9181360
doi: 10.1111/j.1582-4934.2008.00682.x
Zhang, L. et al. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Nat. Cell Biol. 14, 717–726 (2012).
pubmed: 22706160
doi: 10.1038/ncb2522
Zhang, J. et al. The regulation of TGF-β/SMAD signaling by protein deubiquitination. Protein Cell 5, 503–517 (2014).
pubmed: 24756567
pmcid: 4085288
doi: 10.1007/s13238-014-0058-8
Xiao, N. et al. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. Biochem. J. 441, 979–986 (2012).
pubmed: 22029577
doi: 10.1042/BJ20111358
Fan, Y. H. et al. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Cell Death Differ. 18, 1547–1560 (2011).
pubmed: 21331078
pmcid: 3136563
doi: 10.1038/cdd.2011.11
Wijnhoven, P. et al. USP4 auto-deubiquitylation promotes homologous recombination. Mol. Cell 60, 362–373 (2015).
pubmed: 26455393
pmcid: 4643306
doi: 10.1016/j.molcel.2015.09.019
Song, E. J. et al. The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes Dev. 24, 1434–1447 (2010).
pubmed: 20595234
pmcid: 2895201
doi: 10.1101/gad.1925010
Yang, J. et al. Cutting edge: ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORgammat. J. Immunol. 194, 4094–4097 (2015).
pubmed: 25821221
doi: 10.4049/jimmunol.1401451
Narod, S. A. & Foulkes, W. D. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer 4, 665–676 (2004).
pubmed: 15343273
doi: 10.1038/nrc1431
Smith, S. A., Easton, D. F., Evans, D. G. & Ponder, B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat. Genet. 2, 128–131 (1992).
pubmed: 1303261
doi: 10.1038/ng1092-128
Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L. & Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 9, 444–450 (1995).
pubmed: 7795653
doi: 10.1038/ng0495-444
Yoshikawa, K. et al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin. Cancer Res. 5, 1249–1261 (1999).
pubmed: 10389907
Liu, F. H. et al. CRL4-DCAF8L1 regulates BRCA1 and BARD1 protein stability. Int. J. Biol. Sci. 18, 1434–1450 (2022).
pubmed: 35280675
pmcid: 8898372
doi: 10.7150/ijbs.57178
Choudhury, A. D., Xu, H. & Baer, R. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. J. Biol. Chem. 279, 33909–33918 (2004).
pubmed: 15166217
doi: 10.1074/jbc.M403646200
Chen, Y. et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 270, 789–791 (1995).
pubmed: 7481765
doi: 10.1126/science.270.5237.789